Desipramine ( DrugBank: Desipramine )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
120	Hereditary dystonia	1
156	Rett syndrome	1

120. Hereditary dystonia

---

Clinical trials : 25 /  Drugs : 21 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 2

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03726996 (ClinicalTrials.gov)	January 14, 2019	29/10/2018	Desipramine in Infantile Neuroaxonal Dystrophy (INAD).	Novel Off-label Use of Desipramine in Infantile Neuroaxonal Dystrophy: Targeting the Sphingolipid Metabolism Pathway to Reduce Accumulation of Ceramide.	Infantile Neuroaxonal Dystrophy	Drug: Desipramine	Duke University	NULL	Terminated	3 Years	17 Years	All	4	Phase 4	United States

156. Rett syndrome

---

Clinical trials : 40 /  Drugs : 53 - (DrugBank : 19) / Drug target genes : 77 - Drug target pathways : 113

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00990691 (ClinicalTrials.gov)	February 17, 2009	6/10/2009	Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome	Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome	Rett Syndrome	Drug: Administration of a high dose of desipramine;Drug: Administration of a low dose of desipramine;Drug: Administration of a placebo	Assistance Publique Hopitaux De Marseille	NULL	Completed	4 Years	18 Years	Female	36	Phase 2	France